Evidence map›Paper›PMID 24319593›Full record

ReviewAutoimmune diseases2013

Updates on morphea: role of vascular injury and advances in treatment.

Julio C Sartori-Valinotti, Megha M Tollefson, Ann M Reed

Open access · goldAbstract readReview
In one paragraph

Review in Autoimmune diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Generalized morphea after COVID-19 vaccines: a case series.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
  6. Review
  7. Article
  8. Scleroderma Mimickers.Current treatment options in rheumatology · 2016
    Article
  9. Article
  10. Progressive hemifacial atrophy: a review.Orphanet journal of rare diseases · 2015
    Review
  11. Review
  12. Interferon beta-1a-induced morphea.JAAD case reports · 2015
    Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Julio C Sartori-ValinottiThe Department of Dermatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Megha M Tollefson
Ann M Reed
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morphea and systemic sclerosis are fibrosing disorders of the skin that share common inflammatory and immunologic pathways that are responsible for the vascular changes, increased collagen production, and extracellular matrix proliferation seen in both conditions. Recent advances in molecular biology techniques have furthered our knowledge of the potential underlying pathogenic mechanisms and offer new and provocative areas of research for novel diagnostic and therapeutic interventions. This review focuses on the role of vascular injury in the development of morphea, the use of ultrasonography as a diagnostic modality, and well-established and newly proposed treatments.

Identifiers

PMID24319593
PMCPMC3844232
OpenAlexW2156797084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.